Skip to content

Femoral head pathology in Sanfilippo disease.

Femoral head pathology in Sanfilippo disease. - Sanfilippo hip study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37709
Enrollment
40
Registered
2012-05-10
Start date
2012-05-20
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MPS III Sanfilippo disease

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: The patient should have a biochemically diagnosed MPS III, type A, B or C and living in the Netherlands.

Exclusion criteria

Exclusion criteria: The parent or legal representative is unwilling to participate.

Design outcomes

Primary

MeasureTime frame
What is the prevalence of femoral pathology in (Dutch) MPS III patients?

Secondary

MeasureTime frame
Can the abnormalities be classified using the avascular necrosis classification (Herring). Do patients with femoral head pathology have clinical signs and symptoms which may predict the presence of these complications?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)